The Paper Kingdom is a videogame that educates kids about clinical trials. The National Institutes of Health, along with the New England Research Institutes, developed the game to dispel myths… read more →
Heart and blood vessel diseases affect over 82 million Americans and kill more than 813,000 people each year. High blood pressure, heart attack, heart failure, and stroke are all types… read more →
Compassionate use, also known as expanded access, may bring an investigational drug or device to patients with life-threatening conditions. These treatments are not yet FDA approved and little may be known about… read more →
As drug patents for large molecules expire, drug companies are seeking new ways to deliver these pharmaceuticals. Incorporating these agents into topical creams, zapping them into the skin using electrical currents, or… read more →
Although flu activity remains low throughout the country, it won’t be long until the flu becomes widespread. The best way to protect yourself is by getting a flu shot. You… read more →
Today is World Diabetes Day, established in 1991 by WHO and the International Diabetes Federation to mark the birthday of Frederick Banting, who helped with the discovery of insulin. Taking place… read more →
The NIH’s National Institute of Allergy and Infectious Diseases (NIAID) has recently launched a new website called ClinRegs, a database of clinical research regulatory information. Visitors can find overviews of… read more →
Medical experts will meet at the World Health Organization to determine which experimental Ebola drugs to prioritize and how to proceed with those clinical trials. The urgency for an effective Ebola… read more →
Cancer specialists can get an idea of how aggressive a tumor may be with a device that captures cells circulating in the blood. The device may provide a more accurate diagnosis… read more →
Do you have flu symptoms? You may qualify for a flu treatment study. Watch the video below, click here, or call one of our locations to learn more. First Med… read more →